0001656472-21-000029.txt : 20210310
0001656472-21-000029.hdr.sgml : 20210310
20210310173438
ACCESSION NUMBER: 0001656472-21-000029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210308
FILED AS OF DATE: 20210310
DATE AS OF CHANGE: 20210310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GORENSTEIN MICHAEL RYAN
CENTRAL INDEX KEY: 0001797199
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38403
FILM NUMBER: 21731002
MAIL ADDRESS:
STREET 1: 111 PETER STREET, SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M5V 2H1
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cronos Group Inc.
CENTRAL INDEX KEY: 0001656472
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 PETER STREET
STREET 2: SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M5V 2H1
BUSINESS PHONE: (416) 504-0004
MAIL ADDRESS:
STREET 1: 111 PETER STREET
STREET 2: SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M5V 2H1
FORMER COMPANY:
FORMER CONFORMED NAME: PharmaCan Capital Corp.
DATE OF NAME CHANGE: 20151021
4
1
wf-form4_161541565846866.xml
FORM 4
X0306
4
2021-03-08
0
0001656472
Cronos Group Inc.
CRON
0001797199
GORENSTEIN MICHAEL RYAN
111 PETER STREET, SUITE 300
TORONTO
A6
M5V 2H1
ONTARIO, CANADA
1
1
0
0
Executive Chairman
COMMON SHARES
2021-03-08
4
M
0
1200000
0.9701
A
9632536
D
COMMON SHARES
2021-03-08
4
F
0
410589
9.5354
D
9221947
D
COMMON SHARES
2021-03-09
4
S
0
185000
9.9962
D
9036947
D
COMMON SHARE OPTION (right to buy)
0.9701
2021-03-08
4
M
0
1200000
0
D
2021-10-06
COMMON SHARES
1200000.0
0
D
The price reported was converted from the Canadian exercise price of C$1.23 to U.S. dollars using an exchange rate of C$1.00 to US$0.7887 as reported by Bloomberg as of March 5, 2021.
Cronos Group Inc. (the "Company") withheld 410,589 common shares underlying the options for payment of the exercise price and to cover applicable withholding taxes, using the closing price of the Company's common shares on March 5, 2021 of C$12.09 as reported on the Toronto Stock Exchange.
The price reported is in U.S. dollars based on the exchange rate of C$1.00 to US$0.7887 as reported by Bloomberg as of March 5, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.90 to $10.07, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.
The options were granted October 6, 2016 and vest in monthly installments over a four-year period.
/s/ Eileen Uy, as attorney-in-fact for Michael R. Gorenstein
2021-03-10